Halbert Hargrove Global Advisors
WST icon

Halbert Hargrove Global Advisors’s West Pharmaceutical WST Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1
Closed -$464 – 703
2026
Q2 		$464 Buy
+1
New +$306 ﹤0.01% 542
2025
Q4 		– Sell
-13
Closed -$3.41K – 749
2025
Q3 		$3.41K Buy
+13
New +$3.16K ﹤0.01% 478
2025
Q2 		– Sell
-1
Closed -$224 – 669
2025
Q1 		$224 Buy
+1
New +$276 ﹤0.01% 584

Other funds holding WST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Halbert Hargrove Global Advisors's WST Position: Q3 2026 in Review

Halbert Hargrove Global Advisors sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 1 share — an estimated $464 sold.

Halbert Hargrove Global Advisors first reported a position in WST in Q1 2025 and held it in 3 quarters. The position peaked at $3.41K in Q3 2025. 515 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Halbert Hargrove Global Advisors reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 1 West Pharmaceutical share in Q3 2026, an estimated $464.
  • Halbert Hargrove Global Advisors first reported a position in West Pharmaceutical in Q1 2025 and held it in 3 quarters.
  • Halbert Hargrove Global Advisors's West Pharmaceutical position peaked at $3.41K in Q3 2025.
  • 515 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.